SEC Form 4 · accession 0001209191-18-030144
Corbus Pharmaceuticals Holdings, Inc. · CRBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P Hochman
Director
Period of report
May 14, 2018
Accepted (ET)
May 15, 2018 · 2:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001595097
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 14, 2018 | P | 5,000 | $5.475 | A | 5,000 | I | By DPH 2008 Trust |
| Common Stock | holding | — | — | — | 459,500 | D | ||
| Common Stock | holding | — | — | — | 4,300 | I | By Solomon Asher Hochman Trust of 2005 | |
| Common Stock | holding | — | — | — | 4,300 | I | By Hannah Hochman Trust of 2007 | |
| Common Stock | holding | — | — | — | 4,300 | I | By Judah Herman Hochman Trust of 2009 | |
| Common Stock | holding | — | — | — | 225,000 | I | By NSH 2008 Family Trust |
Table II — derivative securities
No Table II lines on this filing.